US panel gives go-ahead of 3rd shot only to those over 65 or at high risk; officials concerned decision undermines efforts to make Green Pass available to those with booster shots
Experts overwhelmingly reject proposal to okay 3rd dose of Pfizer vaccine for anyone over 16, questioning whether data presented on Israel's booster campaign is applicable to US
As US officials set to mull okaying Pfizer's 3rd dose, data from a million Israelis shows it boosts protection from infection tenfold compared with eligible people who got 2 shots
Health officials deny country signed an exclusive deal with pharma giant, noting that Moderna shots are also administered; pharmaceutical company clarifies comments
The variant was 27 times more likely to break through Pfizer protection from January-February and cause symptoms than it was to penetrate natural immunity from the same period
Recent comments